NumerixS Investment Technologies’s ANI Pharmaceuticals ANIP Stock Holding History

NumerixS Investment Technologies’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,900	Closed	-$168K	–	1109
2018 Q1	$168K	Buy	2,900 +400	+16%	+$25.4K	0.04%	467
2017 Q4	$161K	Hold	2,500	–	–	0.04%	526
2017 Q3	$131K	Buy	2,500 +600	+32%	+$28.6K	0.03%	655
2017 Q2	$89K	Sell	1,900 -614	-24%	-$29.6K	0.01%	853
2017 Q1	$124K	Buy	+2,514	New	+$141K	0.01%	837
2016 Q4	–	Sell	-1,300	Closed	-$86K	–	1107
2016 Q3	$86K	Buy	+1,300	New	+$81.3K	0.01%	862
2015 Q2	–	Sell	-4,700	Closed	-$294K	–	622
2015 Q1	$294K	Buy	+4,700	New	+$286K	0.05%	446

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

NumerixS Investment Technologies's ANIP Position: Q2 2018 in Review

NumerixS Investment Technologies sold out of ANI Pharmaceuticals (ANIP) in Q2 2018, closing a stake of 2,900 shares — an estimated $168K sold.

NumerixS Investment Technologies first reported a position in ANIP in Q1 2015 and held it in 7 quarters. The position peaked at $294K in Q1 2015. 184 funds tracked by Wall St. Rank hold ANIP as of Q2 2018.

NumerixS Investment Technologies reported no remaining ANI Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
NumerixS Investment Technologies sold 2,900 ANI Pharmaceuticals shares in Q2 2018, an estimated $168K.
NumerixS Investment Technologies first reported a position in ANI Pharmaceuticals in Q1 2015 and held it in 7 quarters.
NumerixS Investment Technologies's ANI Pharmaceuticals position peaked at $294K in Q1 2015.
184 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2018.

Based on NumerixS Investment Technologies's 13F filing for Q2 2018, filed 10 Aug 2018.